You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 18, 2025

Details for Patent: 10,130,585


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,130,585 protect, and when does it expire?

Patent 10,130,585 protects LODOCO and is included in one NDA.

This patent has thirty-seven patent family members in twenty-five countries.

Summary for Patent: 10,130,585
Title:Methods of treating and/or preventing cardiovascular disease
Abstract:Methods of treating or preventing cardiovascular disease and/or inflammatory disease in mammalian subjects comprising the administration of the novel formulations disclosed herein are provided.
Inventor(s):Susanne Riel
Assignee:Murray and Poole Enterprises Ltd
Application Number:US14/563,537
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,130,585

Introduction

United States Patent 10,130,585, titled "Methods of treating and/or preventing cardiovascular disease," is a patent that outlines innovative methods for addressing cardiovascular and inflammatory diseases. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication Number and Authority The patent in question is US10130585B2, issued by the United States Patent and Trademark Office (USPTO)[4].

Scope of the Invention

Background and Purpose The patent describes methods for treating or preventing cardiovascular disease and/or inflammatory disease in mammalian subjects. The invention involves the administration of specific formulations, particularly focusing on the use of colchicine in a sustained release formulation. This approach aims to provide therapeutic benefits while minimizing side effects associated with traditional dosing regimens.

Claims

Independent and Dependent Claims The patent includes both independent and dependent claims that define the scope of the invention.

  • Independent Claims: These claims stand alone and define the broadest scope of the invention. For example, Claim 1 might describe the method of treating cardiovascular disease using a sustained release formulation of colchicine[4].
  • Dependent Claims: These claims build upon the independent claims and provide additional specifics or limitations. For instance, a dependent claim might specify the dosage regimen, the type of sustained release formulation, or the particular cardiovascular condition being treated[4].

Detailed Claim Analysis

Claim Elements Each claim includes several key elements:

  • Active Agent: The use of colchicine as the active agent.
  • Formulation: The specific type of sustained release formulation.
  • Administration: The method and frequency of administration.
  • Therapeutic Effect: The intended therapeutic outcome, such as treating or preventing cardiovascular disease[4].

Prior Art and Novelty

Prior Art Keywords The patent lists prior art keywords such as "colchicine," "sustained release," "formulation," and "release formulation." These keywords indicate the existing knowledge in the field and highlight the novelty of the invention by distinguishing it from prior art[4].

Classification

International Classification The patent is classified under A61P9/00, which pertains to drugs for disorders of the cardiovascular system. More specifically, it falls under A61P9/10, which includes drugs for treating ischemic or atherosclerotic diseases[4].

Pharmaceutical Aspects

Pharmacokinetics The patent discusses pharmacokinetic parameters such as the area under the curve (AUC) of plasma concentration versus time, terminal elimination rate constant (Ke or Kel), and terminal elimination half-life (t1/2). These parameters are crucial in understanding the efficacy and safety profile of the sustained release formulation[4].

Patent Landscape

Global Patent Family To understand the broader patent landscape, it is essential to look at the patent family for this specific application. The Global Dossier service provided by the USPTO allows users to see related applications filed at participating IP Offices, including the dossier, classification, and citation data for these applications[1].

Search and Analysis Tools

USPTO Resources Several tools are available for searching and analyzing patents, including the Patent Public Search tool, which provides enhanced access to prior art. The Common Citation Document (CCD) application consolidates citation data from multiple offices, helping to visualize the global patent landscape for the same invention[1].

Economic and Research Implications

Patent Claims Research Dataset The USPTO's Patent Claims Research Dataset can provide insights into the trends and measurements of patent scope. This dataset, which includes claims from US patents granted between 1976 and 2014, can help in understanding the broader context of patent claims and their economic implications[3].

Legal and Policy Considerations

Small Claims Patent Court The concept of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could impact the enforcement and litigation landscape for patents like US10130585B2. Such a court could provide a more streamlined and cost-effective way to resolve patent disputes, which might influence how inventors and companies approach patent protection and enforcement[2].

Key Takeaways

  • Invention Scope: The patent covers methods for treating or preventing cardiovascular disease using a sustained release formulation of colchicine.
  • Claims Analysis: The claims are structured to define the invention broadly while providing specific details through dependent claims.
  • Prior Art and Novelty: The invention is distinguished from prior art through its unique formulation and administration method.
  • Classification: The patent is classified under relevant international classifications related to cardiovascular diseases.
  • Pharmacokinetics: The patent includes detailed pharmacokinetic parameters to ensure the efficacy and safety of the formulation.
  • Patent Landscape: Understanding the global patent family and using tools like Global Dossier and CCD is crucial for comprehensive analysis.
  • Economic and Research Implications: The USPTO's Patent Claims Research Dataset can provide valuable insights into patent trends and economic implications.

FAQs

  1. What is the main focus of United States Patent 10,130,585?

    • The main focus is on methods for treating or preventing cardiovascular disease using a sustained release formulation of colchicine.
  2. How does the patent distinguish itself from prior art?

    • The patent distinguishes itself through its unique sustained release formulation and administration method of colchicine.
  3. What are the key pharmacokinetic parameters discussed in the patent?

    • The patent discusses parameters such as AUC, terminal elimination rate constant (Ke or Kel), and terminal elimination half-life (t1/2).
  4. What tools can be used to analyze the global patent landscape for this invention?

    • Tools such as the Global Dossier and the Common Citation Document (CCD) can be used to analyze the global patent landscape.
  5. How might the concept of a small claims patent court impact this patent?

    • A small claims patent court could provide a more streamlined and cost-effective way to resolve patent disputes related to this invention.

Sources

  1. USPTO - Search for patents

  2. ACUS - U.S. Patent Small Claims Court

  3. USPTO - Patent Claims Research Dataset

  4. Google Patents - Methods of treating and/or preventing cardiovascular disease

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,130,585

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Agepha Pharma Fz LODOCO colchicine TABLET;ORAL 215727-001 Jun 16, 2023 RX Yes Yes 10,130,585 ⤷  Try for Free A METHOD OF TREATING CARDIOVASCULAR DISEASE ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,130,585

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014255434 ⤷  Try for Free
Australia 2019201048 ⤷  Try for Free
Australia 2020294268 ⤷  Try for Free
Australia 2024205185 ⤷  Try for Free
Brazil 112015026418 ⤷  Try for Free
Canada 2909370 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.